Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4‐Deficient
Pathology International · 2026
DOI: 10.1111/pin.70095 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, 2026. Verfasst von Heng Zheng und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhejiang Hospital, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Adenocarcinoma, Mucinous, Carcinoma, Non-Small-Cell Lung, DNA Helicases, Lung Neoplasms. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
SMARCA4-deficient non-small cell lung cancer is characterized by highly aggressive clinical behavior, diverse tumor subtypes, and complex histological features. The application of the SMARCA4 immunohistochemical marker facilitates accurate identification. This study presents a rare case of SMARCA4-deficient pulmonary invasive mucinous adenocarcinoma with high-grade transformation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Zhejiang Hospital, Hangzhou, Zhejiang, China.
- Department of General Surgery, Yuyao Traditional Chinese Medicine Hospital, Ningbo, Zhejiang, China.
- Department of Radiology, Zhejiang Hospital, Hangzhou, Zhejiang, China.
Zitieren
APA
Zheng, H., Cui, Y., Fu, F., Peng, F., & Dai, X. (2026). Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4‐Deficient. Pathology International. https://doi.org/10.1111/pin.70095
Vancouver
Zheng H, Cui Y, Fu F, Peng F, Dai X. Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4‐Deficient. Pathology International. 2026. doi:10.1111/pin.70095
BibTeX
@article{Zheng2026,
author = {Zheng, Heng and Cui, Yingying and Fu, Fengli and Peng, Fang and Dai, Xiaomin},
title = {Progressive Development of Pulmonary Invasive Mucinous Adenocarcinoma With SMARCA4‐Deficient},
journal = {Pathology International},
year = {2026},
doi = {10.1111/pin.70095}
}
EUVIMED